$0.076600
0.00050.66%
Last update: 9:22 AM
15 minutes delayed
Comments
Loading...
ENDRA Life Sciences
NDRANASDAQ
ENDRA Life Sciences (NASDAQ:NDRA) Stock, Analyst Ratings, Price Targets, Forecasts
ENDRA Life Sciences Inc has a consensus price target of $8.5 based on the ratings of 2 analysts. The high is $9 issued by HC Wainwright & Co. on March 31, 2023. The low is $8 issued by Ascendiant Capital on June 7, 2024. The 3 most-recent analyst ratings were released by Ascendiant Capital, HC Wainwright & Co., and HC Wainwright & Co. on June 7, 2024, March 31, 2023, and April 7, 2022, respectively. With an average price target of $7.33 between Ascendiant Capital, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 10001.01% upside for ENDRA Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for ENDRA Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/07/2024 | Buy Now | 10919.28% | Ascendiant Capital | Edward Woo | $10 → $8 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 12296.69% | HC Wainwright & Co. | Vernon Bernardino | $100 → $9 | Reiterates | → Buy | Get Alert |
| 04/07/2022 | Buy Now | 6787.05% | HC Wainwright & Co. | Vernon Bernardino | $120 → $100 | Maintains | Buy | Get Alert |
FAQ
What is the target price for ENDRA Life Sciences (NDRA) stock?
The latest price target for ENDRA Life Sciences (NASDAQ:NDRA) was reported by Ascendiant Capital on June 7, 2024. The analyst firm set a price target for $8.00 expecting NDRA to rise to within 12 months (a possible 10343.86% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ENDRA Life Sciences (NDRA)?
The latest analyst rating for ENDRA Life Sciences (NASDAQ:NDRA) was provided by Ascendiant Capital, and ENDRA Life Sciences maintained their buy rating.
When was the last upgrade for ENDRA Life Sciences (NDRA)?
There is no last upgrade for ENDRA Life Sciences
When was the last downgrade for ENDRA Life Sciences (NDRA)?
There is no last downgrade for ENDRA Life Sciences.
When is the next analyst rating going to be posted or updated for ENDRA Life Sciences (NDRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ENDRA Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ENDRA Life Sciences was filed on June 7, 2024 so you should expect the next rating to be made available sometime around June 7, 2025.
Is the Analyst Rating ENDRA Life Sciences (NDRA) correct?
While ratings are subjective and will change, the latest ENDRA Life Sciences (NDRA) rating was a maintained with a price target of $10.00 to $8.00. The current price ENDRA Life Sciences (NDRA) is trading at is $0.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.